Overall rank by patents
#31,575
of 49,997 tracked assignees
USPTO PatentsView assignee record - 8 granted patents across 18 technology areas, recorded in grant years 2015–2022. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: B05D (Processes FOR Applying Fluent Materials TO Surfaces, IN General).
The verdict
According to USPTO PatentsView, Europlasma ranks #31,575 of 49,997 tracked US assignees by granted-patent volume, with 8 patents across 18 technology areas.
USPTO PatentsView assignee plate
Corpus R31575 · Foreign Corporation #31,575 · 8 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-FLAT · BOOK-FULL
Nearest grant-volume peer: ESS 2 Tech, LLC (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Europlasma · this assignee
32 score
3D Lighting… · lowest
7 score
What this shows Europlasma's Innovation Score is 31.9/100 (39th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Europlasma NV is a focused PatentsView assignee: 18 CPC subclasses with 62.5% of grants classified under B05D (Processes FOR Applying Fluent Materials TO Surfaces, IN General). Peak complete grant year is 2019 (2 grants) versus a trough of 1 in 2015. By volume, Europlasma sits between ESS 2 Tech, LLC and Everpads Co., Ltd..
Europlasma NV shows 1 grants in 2022–2024 against only 5 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
ESS 2 Tech, LLC
8 patents
Estetra SRL
8 patents
Estorm Co., Ltd.
8 patents
Etas Embedded Systems Canada Inc.
8 patents
Everfront Biotech Inc.
8 patents
Evergreen Nursery
8 patents
Everhard Industries PTY Ltd
8 patents
Everpads Co., Ltd.
8 patents
Europlasma NV
8 patents
What this shows Europlasma holds 8 patents at rank #31,528, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #31,528 in granted patent volume.
Other assignees with the most granted patents in Europlasma's primary technology class.
Europlasma's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
32 39th percentile higher than 39% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 1 | 12.5% |
| 2017 | 1 | 12.5% |
| 2019 | 2 | 25.0% |
| 2020 | 1 | 12.5% |
| 2021 | 2 | 25.0% |
| 2022 | 1 | 12.5% |
Top 15 of 18 technology areas
Overall rank by patents
#31,575
of 49,997 tracked assignees
31.9 out of 100
What to do with this data
Europlasma NV's patent record in context - here's where to go next.
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.